Journal of neuro-oncology

Link between DNA repair enzyme levels and survival in older glioblastoma patients treated with radiation and chemotherapy

Circadian Biology Weekly Brief ↗PubMed ↗DOI ↗

Updated

Abstract

Median overall survival (OS) was 15.3 months for patients with methylated MGMT promoters, compared to 10.2 months for those with unmethylated promoters.

  • Epigenetic silencing of the MGMT gene through promoter methylation is linked to improved overall survival (OS) and progression-free survival (PFS) in elderly glioblastoma multiforme (GBM) patients.
  • In a study of 83 patients aged 70 and older, 50.6% had methylated MGMT promoters.
  • Median PFS was 10.5 months for patients with methylated tumors, while it was 5.5 months for those with unmethylated tumors.
  • MGMT methylation status was identified as the strongest independent prognostic factor for OS and PFS.
  • Statistical analyses indicated significant differences in survival outcomes based on MGMT methylation status.

Simplified

Full Text

Full text is available at the source.
View Full Text ↗

Related papers

Mar '12
MGMT gene methylation linked to outcomes in glioblastoma patients treated with temozolomide and radiation
top 5% journal
cited by 45 papers
research support, non-u.s. gov't
Jan '13
Using DNA repair protein levels and gene regulation to better predict glioblastoma outcomes
top 1% journal
cited by 98 papers
research support, n.i.h., extramural
Feb '13
Benefits of temozolomide combined with radiotherapy in standard treatment for new glioblastoma cases
cited by 22 papers
comparative study
Dec '14
Long-term temozolomide treatment is possible for new glioblastoma patients: experience with up to 101 treatment cycles
top 20% journal
cited by 67 papers
journal article
May '18
Comparing two tests for detecting MGMT gene changes in glioblastoma patients
top 10% journal
cited by 16 papers
journal article
Apr '06
MGMT gene changes linked to better survival and response to temozolomide in children with aggressive brain tumors
top 20% journal
cited by 163 papers
research support, non-u.s. gov't
Aug '15
MGMT gene inactivation and treatment response in new glioblastoma patients receiving Gliadel
top 30% journal
cited by 19 papers
research support, non-u.s. gov't
Oct '15
IDH mutation and MGMT gene changes in glioblastoma: findings from a forward-looking patient registry
top 30% journal
cited by 133 papers
research support, non-u.s. gov't
Dec '12
MGMT gene changes and protein levels linked to outcomes in glioblastoma patients treated with chemotherapy and radiotherapy
top 5% journal
cited by 65 papers
research support, non-u.s. gov't
Nov '08
MGMT Gene Methylation and Its Link to Temozolomide Response in Brain Tumor Models
top 20% journal
cited by 79 papers
research support, n.i.h., extramural

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the circadian biology brief

issue #50
Afternoon workouts beat morning sessions for fat loss — and your genes may explain why
6 days ago7 studies
issue #49
Your body clock controls which drugs work — and a protein called gp78 is why
1 week ago7 studies
issue #48
A blood test can now estimate your internal clock time using just 60 proteins
2 weeks ago7 studies
issue #47
Your body clock controls liver fibrosis — and scientists just found the on/off switch
3 weeks ago7 studies
issue #46
Night shift workers' metabolomes fall out of sync — and glucose pays the price
4 weeks ago7 studies
issue #45
80% of FDA-approved drug targets show clock-dependent activity — timing may be everything
5 weeks ago7 studies
issue #44
Sleeping late on weekends is independently linked to higher cardiovascular disease risk
6 weeks ago7 studies
issue #43
A smartphone app cut mood episode recurrence 3.4x in people with depression and bipolar disorder
7 weeks ago7 studies
issue #42
Morning cancer immunotherapy linked to 49% vs 40% disease control rate in 969 patients
8 weeks ago7 studies
issue #41
Timing cancer treatment before 3pm nearly doubled survival in lung cancer patients
9 weeks ago7 studies
explore the archive
See more issues from the circadian biology brief